Pemphigus is another skin condition that causes blisters. It happens when the skin layers break down and blisters form inside the skin itself. There are different types, like Pemphigus Vulgaris.
Every report comes from a Lived member, sent anonymously.
Have you tried Rituximab for Pemphigus?
Pemphigus is a group of rare autoimmune diseases in which the immune system attacks the proteins that hold skin cells together. When those connections give way, fragile blisters form in the skin or in the moist linings of the body, such as the inside of the mouth. The blisters are soft and break open easily, leaving raw, painful sores that tend to heal slowly. Pemphigus is not contagious, but it is a serious condition that needs treatment. The two main types differ in where they appear. Pemphigus vulgaris, the most common type, often starts in the mouth: about half to two thirds of people with it have painful mouth sores before any blisters appear on the skin. It can also affect the throat, nose, eyes and genitals. Pemphigus foliaceus affects only the skin, often the face, scalp and upper body, where blisters break quickly and leave crusted sores. Rarer forms include pemphigus triggered by a medicine and paraneoplastic pemphigus, which develops alongside a tumor. Pemphigus is a different disease from bullous pemphigoid, another autoimmune blistering condition. Pemphigoid mainly affects older adults and causes deeper, often itchy blisters that do not break as easily.
In pemphigus, the immune system makes antibodies against desmogleins, proteins that help neighboring skin cells stick to one another. Once these antibodies bind, the cells separate and a blister forms within the outer layer of skin. Why the immune system starts doing this is not known. Pemphigus does not appear to be inherited, although some people's genes make them more susceptible. Pemphigus vulgaris usually begins between ages 50 and 60, affects men and women about equally and is rare in children. Risk is higher in people of Ashkenazi Jewish or Mediterranean ancestry and in people who have another autoimmune disease, particularly myasthenia gravis. Because pemphigus is rare, most people with these risk factors never develop it. Some medicines can cause pemphigus. The best known is penicillamine, used for Wilson's disease and rheumatoid arthritis. Certain blood pressure medicines (ACE inhibitors and angiotensin receptor blockers) and cephalosporin antibiotics have also been linked. Paraneoplastic pemphigus occurs alongside a tumor, often one involving the lymph nodes, tonsils, spleen or thymus, which may be benign or cancerous. In people who already have pemphigus, dermatologists also point to certain drugs, surgery, radiation and injury to the skin as possible triggers for flares.
Many conditions cause blisters and mouth sores, so pemphigus needs to be confirmed by a dermatologist, ideally one experienced with blistering diseases. The exam looks at the blisters, sores and crusts, and the doctor may gently rub normal-looking skin near a blister. In pemphigus, the top layer of skin often slides away under light pressure. A skin biopsy is the key test. One small sample from a fresh blister is examined under a microscope for the characteristic splitting between skin cells. A second sample from nearby normal-looking skin is checked with direct immunofluorescence, a staining technique that shows antibodies attached to the surface of skin cells. Blood tests can measure antibodies against desmoglein 1 and desmoglein 3. A diagnosis is made when the symptoms and microscope findings fit pemphigus and either the immunofluorescence test or the blood test confirms the antibodies. The assessment also includes a full list of medicines, including nonprescription ones, since some can cause or worsen pemphigus. The doctor will gauge how much of the skin and mouth is involved and review conditions such as diabetes, high blood pressure or bone thinning, because they affect how safely long courses of steroids can be used.
Pemphigus needs treatment that calms the immune system. Without it, the disease tends to worsen and can become life threatening, mainly through infection and fluid loss from widespread sores. There is no cure, but treatment controls pemphigus in most people, and many reach remission and can stop medicine for a time. Corticosteroids such as prednisone, taken by mouth, have long been the backbone of treatment because they stop new blisters from forming. The drawback is that pemphigus often needs high doses for months, which brings well-known side effects: high blood sugar or diabetes, raised blood pressure, muscle weakness, bone thinning, cataracts, glaucoma, mood changes and a higher risk of infection. Much of modern treatment aims to use less steroid for a shorter time. For moderate to severe pemphigus, international experts now include rituximab (Rituxan, also available as biosimilar versions) as a first-line option alongside steroids. Rituximab is an antibody medicine given by intravenous infusion that removes the immune cells that produce the harmful antibodies. In a French trial of people with newly diagnosed pemphigus, 89% of those given rituximab with a short steroid course were in complete remission off all treatment after two years, compared with 34% of those given steroids alone, and the rituximab group had fewer side effects. In the US it is approved for moderate to severe pemphigus vulgaris in adults, and European guidelines also recommend it for pemphigus foliaceus. Its trade-offs include infusion reactions, a higher risk of serious infections, a blood test for hepatitis B beforehand because the virus can reactivate, and the need to avoid live vaccines. Flares can still happen, and some people need repeat infusions. Steroid-sparing pills, mainly azathioprine and mycophenolate mofetil (CellCept), are immune-suppressing medicines used with steroids so the steroid dose can come down, and they require regular blood tests. Mycophenolate raises the risk of miscarriage and birth defects, so people who could become pregnant need to plan contraception with their doctor. In a trial comparing the two directly in pemphigus vulgaris, rituximab produced lasting remission more often than mycophenolate (40% versus 10% at one year) and allowed less steroid use, but caused more serious side effects. When disease does not respond, options include intravenous immunoglobulin (IVIG, concentrated antibodies from donated blood), immunoadsorption to filter antibodies out of the blood, and cyclophosphamide, a stronger immune-suppressing drug. Care for the sores matters too. Strong steroid creams, steroid injections into stubborn sores and steroid gels for the mouth can help alongside the main treatment. Gentle wound care with nonstick dressings, numbing gels, pain relief, dental care and prompt treatment of infections all support healing. People on long-term steroids usually take calcium and vitamin D, and some also take a medicine to protect their bones. Widespread disease often needs a hospital stay until the blistering is under control.
Pemphigus is usually a long-term condition that moves through phases. Once treatment takes hold, new blisters stop forming, but existing sores heal slowly, often over one to three months. When the skin is largely healed, the steroid dose is lowered step by step over months. Visits are frequent at first, often every one to two weeks, then about monthly while steroids are reduced, and every few months once the disease is quiet. Blood tests for desmoglein antibodies are repeated along the way, because antibody levels tend to rise and fall with disease activity and can help guide decisions about lowering treatment. Many people reach complete remission, and some eventually stop all treatment. Flares are common, particularly while medicine is being reduced, and are usually managed by stepping treatment back up. Healed sores often leave dark spots rather than scars; these fade on their own, though it can take time. Active disease can be hard to live with. Mouth sores can make eating, drinking, talking and brushing teeth painful, and some people lose weight; pain relief, numbing gels and help from a dentist or dietitian can make a real difference. Treatment side effects may need their own care from a primary care doctor or eye doctor. Because treatment weakens the immune system, inactivated vaccines such as flu and pneumococcal shots are still recommended, though they may protect less well, and live vaccines are avoided. Because pemphigus is rare, patient support groups can be a valuable source of information and shared experience.
Make an appointment with a doctor, ideally a dermatologist, for blisters that appear without a clear cause or for mouth sores that do not heal. Many conditions can look similar, and an accurate diagnosis matters because pemphigus needs specific treatment. If you are being treated, contact your care team promptly about new blisters or sores, which can signal a flare, and about fever, chills, aching or feeling generally unwell, since infection is the most serious risk of both the disease and its treatment. Sores that become more red, warm and painful or start draining pus also need attention. Blisters that spread quickly over large areas of skin, or mouth and throat sores so painful that you cannot eat or drink enough, need same-day medical care, as extensive pemphigus usually requires treatment in the hospital.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Pemphigus is like, what's helped you, or ask the community a question.